DAPT score: a game-changer for long-term dual antiplatelet therapy after stenting

Access to the full content of this site is available only to registered healthcare professionals. Register to read more

Christopher P. Cannon, MD

See a slide and audio version of this commentary at our partner site, QuantiaMD (free account required)

One of the biggest problems with antithrombotic therapy is the ever-present balance of reductions in ischemic events with increases in bleeding events. The analogy of...